BRIEF-Nexstim files 510(k) submission for NBT system US FDA
* REG-NEXSTIM PLC FILES 510(K) SUBMISSION FOR ITS NBT® SYSTEM FOR THE TREATMENT OF DEPRESSION WITH US FDA Source text for Eikon: Further company coverage: (Gdynia Newsroom)
May 1 Cardinal Health
* Ceo says "experiencing pricing deflation in generics, some heightened reimbursement pressures which affect our customers"-conf call
* Cardinal health says generic pricing definitely getting better, not quite as good as the company modeled but definitely getting better - conf call Further company coverage:
LONDON, June 26 If central banks have learned anything from the Great Financial Crisis, the worst since the 1930s, it is that you don't need runaway inflation to raise interest rates. Financial market bubbles should be enough.